Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Restricted Stock Awards (Details)

v3.24.3
Stockholders' Equity - Restricted Stock Awards (Details) - Restricted Stock
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Stockholders' Equity  
Non-vested beginning balance | shares 1,316,120
Number of Shares, Granted | shares 5,346,306
Number of Shares, Forfeited | shares (23,894)
Number of Shares, Vested | shares (280,800)
Non-vested ending balance | shares 6,357,732
Weighted Average Exercise Price, beginning balance | $ / shares $ 6.88
Weighted Average Grant Date Fair Value, Granted | $ / shares 1.89
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 6.28
Weighted Average Grant Date Fair Value, Vested | $ / shares 8.40
Weighted Average Exercise Price , ending balance | $ / shares $ 2.62